companydata.dkcompanydata.dk

ALTRAPHARMA Invest ApS: Financial statements 2016

CVR: 34483884

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,154,215 and a net result of DKK 67,430 compared with DKK 6,623 the year before. That is an increase of 36.8% compared with the year before. Equity in the 2016 report amounted to DKK 246,819. The solvency ratio was 16.1%.

Gross Profit
DKK 1,154,215
Profit/Loss
DKK 67,430
Equity
DKK 246,819
Total Assets
DKK 1,536,298
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-1.2 mio.67 t.247 t.0
2015-843 t.7 t.379 t.-
2014-1.4 mio.223 t.623 t.-
2013-1.4 mio.145 t.650 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ALTRAPHARMA Invest ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

ALTRAPHARMA Invest ApS appoints new auditorMay 1, 2016

As of May 1, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of ALTRAPHARMA Invest ApS.

Auditor steps down at ALTRAPHARMA Invest ApSApr 30, 2016

As of April 30, 2016, AP STATSAUTORISEREDE REVISORER P/S has stepped down as auditor of ALTRAPHARMA Invest ApS.

ALTRAPHARMA Invest ApS: The 2015 annual report is outApr 5, 2016

ALTRAPHARMA Invest ApS has published its annual report for 2015. Gross profit came to DKK 843,480, and the net result was DKK 6,623.

About ALTRAPHARMA Invest ApS

ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.

Source: annual report 2025, Danish Business Authority